Microsoft Word - ELCID_Telemax Capital Increase No. FER 600195 March 23, 2018 Subject : Notification of the capital increase and investment plan of its subsidiary Attention : President, The
% The Company and its subsidiaries had other income of Baht 741.35 million, a rise by Baht 375.49 million or 102.63% from the same period of last year. Most of the increase came from the interest income
62.51% to 57.99%. 2. Net investment revenues, gains on investments and fair value losses totally amounted to Baht 30.22 million, an increase of Baht 13.46 million, because of the rise of gains from the
growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing
three-month period ended September 30, 2019 is THB 58.91 million, an increase of THB 31.19 million (112.5%) relative to last year quarter’s. This is mainly due to the following factors: 1. Motor insurance
following table. (Unit: Million Baht) Q2/2016 Q2/2017 Y-O-Y Change Increase/(Decrease) Note Sales Revenue 213.2 196.4 (7.9%) The company's sales revenue for Q2/2017 was THB 196.4 mn and classified from the
brokerage income from reinsurers” total THB 520.10 million for the 2 nd quarter of 2019. This is an increase of THB 55.56 million (12%) relatively to last year figure. Nevertheless, underwriting profit has
together with a rise in revenues from sales of wellness and anti-aging Business Unit at Baht 128.58 million or increase of Baht 34.12 million or 26.54% in 2019 largely from sales of probiotic products such
%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of